Positives

• A patient on a CBD-dominant oil containing CBC reported reduced inflammation-related symptoms during a Long COVID feasibility trial Wiley.
  
  
• A patient said the minor cannabinoid took the edge off pain and mood without the head-change of THC Vice.
  
  

Negatives

• A patient noted that despite preclinical hype for inflammation and neuroprotection, they felt almost nothing from CBC-only products WebMD.
  
  
• A patient complained that most products labeled CBC were really CBD-dominant blends with only trace CBC Wiley.
  
  

Hurdles & Side Effects

• A patient wanted clinical evidence in humans but found only animal and cell studies to guide dosing WebMD.
  
  
• A patient struggled to source isolated CBC at a price that was not several times the cost of CBD or CBG Exploration Publishing.